Induction of new board members at Kenya BioVax Institute

KENYA – Kenya BioVax Institute Limited (KBI) has welcomed two new members to its Board of Directors, marking a significant step in its mission to enhance public health in Kenya.

The newly inducted members, Mr. Edwin Bett from the Kenya Medical Research Institute (KEMRI) and Ms. Cheryl Majiwa, who serves as the alternate to the Principal Secretary at the National Treasury, bring a wealth of experience and expertise that is expected to strengthen KBI’s leadership.

The induction ceremony occurred at KBI’s headquarters in Nairobi, where an atmosphere of optimism prevailed. 

The event was characterized by discussions on the future direction of the institute and its commitment to improving health outcomes for Kenyans. 

“We are excited to have Mr. Bett and Ms. Majiwa on board. Their diverse backgrounds and skills will be instrumental in guiding our strategic initiatives,” said Dr. John Mwangi, KBI’s Chief Executive Officer.

KBI’s vision is centered around advancing public health through innovation and collaboration. The induction of the new board members is seen as a pivotal moment in the institute’s journey toward achieving its goal of a world free from vaccine-preventable diseases. 

The board is tasked with leading the institute into a future characterized by impactful research and sustainable healthcare solutions.

Mr. Bett, who has extensive experience in medical research and public health, expressed his enthusiasm about joining the board. 

“I look forward to working alongside my fellow board members to drive initiatives that will significantly impact public health in Kenya,” he stated.

 His background at KEMRI, a leading research institution, positions him well to contribute to KBI’s objectives.

Ms. Majiwa also shared her thoughts on her new role, emphasizing the importance of ethical leadership in healthcare. 

“It is vital that we approach our work with integrity and a commitment to serving the community. Together, we can create a healthier future for all Kenyans,” she remarked. 

Her experience in the National Treasury will provide valuable insights into the financial aspects of KBI’s operations, ensuring that the institute can effectively allocate resources toward its initiatives.

The induction of the new board members signifies a milestone in KBI’s institutional history and heralds a promising era of progress in biotechnology and public health.

As they embark on their respective roles, the board members are expected to lead efforts to enhance the quality of life for all Kenyans through innovative health solutions.

KBI’s commitment to ethical leadership and collaboration is more critical than ever as the institute navigates public health challenges. 

The new board members are poised to guide KBI in its mission to address pressing health issues and ensure that the institute remains at the forefront of vaccine development and distribution in the region.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE